Yuji Yoshiike

3.4k total citations · 1 hit paper
24 papers, 2.8k citations indexed

About

Yuji Yoshiike is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuji Yoshiike has authored 24 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 13 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuji Yoshiike's work include Alzheimer's disease research and treatments (21 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Yuji Yoshiike is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Yuji Yoshiike collaborates with scholars based in Japan, United States and Taiwan. Yuji Yoshiike's co-authors include Akihiko Takashima, Masahito Yamada, Kenjiro Ono, Hironobu Naiki, Kazuhiro Hasegawa, Miyuki Murayama, Takumi Akagi, Naruhiko Sahara, Yun‐Ru Chen and Tetsuya Kimura and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Yuji Yoshiike

24 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of Concern: Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

2003 587 citations Kenjiro Ono, Yuji Yoshiike et al. Journal of Neurochemistry profile →

Peers

Countries citing papers authored by Yuji Yoshiike

Since Specialization

Citations

This map shows the geographic impact of Yuji Yoshiike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Yoshiike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Yoshiike more than expected).

Fields of papers citing papers by Yuji Yoshiike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Yoshiike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Yoshiike. The network helps show where Yuji Yoshiike may publish in the future.

Co-authorship network of co-authors of Yuji Yoshiike

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Yoshiike. A scholar is included among the top collaborators of Yuji Yoshiike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Yoshiike. Yuji Yoshiike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies 2015 ·Scientific Reports ·Sahabudeen Sheik Mohideen, (unknown), (unknown), Leo Tsuda, Yuji Yoshiike	21
2	Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups 2015 ·Nature Communications ·Yoshiyuki Soeda, Misato Yoshikawa, Osborne F. X. Almeida, Akio Sumioka, Sumihiro Maeda, Hiroyuki Osada, Yasumitsu Kondoh, Akiko Saito, Tomohiro Miyasaka, Tetsuya Kimura, Masaaki Suzuki, Hiroko Koyama, Yuji Yoshiike, Hachiro Sugimoto, Yasuo Ihara, Akihiko Takashima	92
3	Phenolic Compounds Prevent Amyloid β-Protein Oligomerization and Synaptic Dysfunction by Site-specific Binding 2012 ·Journal of Biological Chemistry ·Kenjiro Ono, Lei Li, Yusaku Takamura, Yuji Yoshiike, Li‐Jun Zhu, Fang Han, Xi‐an Mao, Tokuhei Ikeda, Junichi Takasaki, Hisao Nishijo, Akihiko Takashima, David B. Teplow, Michael G. Zagorski, Masahito Yamada	203
4	Negatively Charged Gold Nanoparticles Inhibit Alzheimer's Amyloid‐β Fibrillization, Induce Fibril Dissociation, and Mitigate Neurotoxicity 2012 ·Small ·Yi‐Hung Liao, Yu‐Jen Chang, Yuji Yoshiike, Y. C. Chang, Yun‐Ru Chen	272
5	Adaptive responses to alloxan‐induced mild oxidative stress ameliorate certain tauopathy phenotypes 2011 ·Aging Cell ·Yuji Yoshiike, Shunji Yamashita, Tatsuya Mizoroki, Sumihiro Maeda, Miyuki Murayama, Tetsuya Kimura, Naruhiko Sahara, Yoshiyuki Soeda, Akihiko Takashima	10
6	Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss 2010 ·Journal of Biological Chemistry ·Tetsuya Kimura, Tetsuya Fukuda, Naruhiko Sahara, Shunji Yamashita, Miyuki Murayama, Tatsuya Mizoroki, Yuji Yoshiike, Boyoung Lee, Ioannis Sotiropoulos, Sumihiro Maeda, Akihiko Takashima	72
7	Amyloid Oligomer Conformation in a Group of Natively Folded Proteins 2008 ·PLoS ONE ·Yuji Yoshiike, (unknown), Yo Matsuo, Yun‐Ru Chen, Tetsuya Kimura, Akihiko Takashima	60
8	GABAA Receptor-Mediated Acceleration of Aging-Associated Memory Decline in APP/PS1 Mice and Its Pharmacological Treatment by Picrotoxin 2008 ·PLoS ONE ·Yuji Yoshiike, Tetsuya Kimura, Shunji Yamashita, (unknown), Tatsuya Mizoroki, Miyuki Murayama, Akihiko Takashima	87
9	GSK-3β Is Required for Memory Reconsolidation in Adult Brain 2008 ·PLoS ONE ·Tetsuya Kimura, Shunji Yamashita, (unknown), (unknown), Miyuki Murayama, Tatsuya Mizoroki, Yuji Yoshiike, Naruhiko Sahara, Akihiko Takashima	117
10	Molecular chaperone‐mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain 2007 ·Journal of Neuroscience Research ·Naruhiko Sahara, Sumihiro Maeda, Yuji Yoshiike, Tatsuya Mizoroki, Shunji Yamashita, Masanori Murayama, (unknown), Yuko Saito, Shigeo Murayama, Akihiko Takashima	70
11	Pore-Forming Proteins Share Structural and Functional Homology with Amyloid Oligomers 2007 ·NeuroMolecular Medicine ·Yuji Yoshiike, Rakez Kayed, Saskia Milton, Akihiko Takashima, Charles Glabe	63
12	Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild‐type human tau 2007 ·The EMBO Journal ·Tetsuya Kimura, Shunji Yamashita, Tetsuya Fukuda, (unknown), Miyuki Murayama, Tatsuya Mizoroki, Yuji Yoshiike, Naruhiko Sahara, Akihiko Takashima	125
13	Granular Tau Oligomers as Intermediates of Tau Filaments 2007 ·Biochemistry ·Sumihiro Maeda, Naruhiko Sahara, Yuko Saito, Miyuki Murayama, Yuji Yoshiike, Hyonchol Kim, Tomohiro Miyasaka, Shigeo Murayama, Atsushi Ikai, Akihiko Takashima	243
14	Surface Structure of Amyloid-β Fibrils Contributes to Cytotoxicity 2007 ·Biochemistry ·Yuji Yoshiike, Takumi Akagi, Akihiko Takashima	96
15	Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro 2004 ·Experimental Neurology ·Kenjiro Ono, Yuji Yoshiike, Akihiko Takashima, Kazuhiro Hasegawa, Hironobu Naiki, Masahito Yamada	110
16	Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation 2003 ·Journal of Biological Chemistry ·Yuji Yoshiike, Dehua Chui, Takumi Akagi, Nobuo Tanaka, Akihiko Takashima	88
17	Expression of Concern: Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease breakdown → 2003 ·Journal of Neurochemistry ·Kenjiro Ono, Yuji Yoshiike, Akihiko Takashima, Kazuhiro Hasegawa, Hironobu Naiki, Masahito Yamada	587
18	Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer's β‐amyloid fibrils in vitro 2002 ·Journal of Neurochemistry ·Kenjiro Ono, Kazuhiro Hasegawa, Yuji Yoshiike, Akihiko Takashima, Masahito Yamada, Hironobu Naiki	104
19	Formation of Filamentous Tau Aggregations in Transgenic Mice Expressing V337M Human Tau 2001 ·Neurobiology of Disease ·Kentaro Tanemura, Takumi Akagi, Miyuki Murayama, (unknown), Ohoshi Murayama, (unknown), Yuji Yoshiike, Jungmi Park, Keiko Matsuda, (unknown), Xiaoyan Sun, Shinji Sato, (unknown), Akihiko Takashima	97
20	New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity 2001 ·Journal of Biological Chemistry ·Yuji Yoshiike, Kentaro Tanemura, Ohoshi Murayama, Takumi Akagi, Miyuki Murayama, Shinji Sato, Xiaoyan Sun, Nobuo Tanaka, Akihiko Takashima	219

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact